Docetaxel albumin bound(Sichuan Kelun)

多西他赛（白蛋白结合型）（四川科伦）

Report date: 2024/08/21 18:01:44

Base Information

Drug NameDocetaxel albumin bound(Sichuan Kelun)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan Kelun Pharmacy Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Kelun Pharmacy Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A